XML 35 R24.htm IDEA: XBRL DOCUMENT v3.25.2

SEGMENT INFORMATION (Tables)

6 Months Ended

Jun. 30, 2025

Segment Reporting [Abstract]

Schedule of segment reporting information

Schedule of segment reporting information
		Three Months Ended June 30,
		2025				2024
Total revenues		$	70,588			$	26,840
Less:
Cost of revenues (excluding amortization and depreciation)			22,838				7,247
Research and development expense (excluding share-based compensation expense):
Clinical trials			122,176				9,587
Halo Project			90,534				118,299
Desktop project			11,700				41,524
Other research and development			1,364				-
Selling, general and administrative and Salaries and Benefits expense (excluding stock based compensation and amortization expense)			687,012				594,161
Amortization			5,125				3,793
Stock based compensation			572,100				308,283
Professional fees			178,597				240,967
Interest income, net			(4,690	)			(66	)
Equity in net (income) loss from equity method investees			-				1,291
Other income			(35,181	)			(13,753	)
Segment net loss			(1,580,987	)			(1,284,493	)
Reconciliation of net loss
Adjustments and reconciling items			-				-
Consolidated net loss		$	(1,580,987	)		$	(1,284,493	)

		Six Months Ended June 30,
		2025				2024
Total revenues		$	111,603			$	105,511
Less:
Cost of revenues (excluding amortization and depreciation)			36,396				16,403
Research and development expense (excluding share-based compensation expense):
Clinical trials			201,578				10,825
Halo Project			388,571				221,776
Desktop project			35,413				41,523
Other research and development			6,500				953
Selling, general and administrative and Salaries and Benefits expense (excluding stock based compensation  and amortization expense)			1,309,958				1,239,882
Amortization			9,912				6,454
Stock based compensation			1,208,945				469,632
Professional fees			546,413				468,796
Interest income, net			(5,793	)			(370	)
Equity in net (income) loss from equity method investees			1,048				(4,492	)
Other income			(58,014	)			(40,221	)
Segment net loss			(3,569,324	)			(2,325,650	)
Reconciliation of net loss
Adjustments and reconciling items			-				-
Consolidated net loss		$	(3,569,324	)		$	(2,325,650	)

X

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-25

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-30

+ Details

Name:	us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration